Backbone modification of nucleic acids: synthesis, structure and therapeutic applications.

  • Micklefield J
  • 19


    Mendeley users who have this article in their library.
  • 156


    Citations of this article.


Nucleic acids have been extensively modified by replacing the phosphodiester group or the whole sugar phosphodiester with alternative anionic, neutral and cationic structures. Several of these modified oligonucleotides exhibit improved properties including enhanced recognition and binding to RNA, duplex DNA and proteins. This has resulted in the development of new and more potent antisense and antigene agents, as well as aptamers. Furthermore, backbone modified oligonucleotides have also been used in the development of several alternative strategies, which rely on altogether different mechanisms of action and show significant promise for therapeutic intervention. In this review the latest advances in the synthesis and evaluation of the most promising backbone modified oligos will be discussed, with a view to their future as novel pharmaceuticals.

Author-supplied keywords

  • Amides
  • Amides: chemistry
  • Boranes
  • Boranes: chemistry
  • Drug Design
  • Nucleic Acid Conformation
  • Nucleic Acids
  • Nucleic Acids: chemistry
  • Nucleic Acids: therapeutic use
  • Organophosphorus Compounds
  • Organophosphorus Compounds: chemistry
  • Peptide Nucleic Acids
  • Peptide Nucleic Acids: chemistry
  • Phosphoric Acids
  • Phosphoric Acids: chemistry
  • Prodrugs
  • Prodrugs: chemistry
  • Prodrugs: therapeutic use

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • J Micklefield

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free